NEWS
UBS and Freehills in CSR tent as France’s Saint-Gobain lobs bid
SYDNEY: CSR is working with UBS bankers after the building materials group received a takeover… read more
Lilly’s Alzheimer’s super drug to be approved ‘any day’
MELBOURNE: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US… read more
Medibank falls on growth guidance disappointing share market
SYDNEY: Further investment in healthcare and promises that its business remains resilient as economic conditions… read more
